Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies
Open Access
- 30 October 2018
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 19 (1) , 1-3
Abstract
Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies. Expert Review of Neurotherapeutics. Accepted 23 October 2018.Keywords
Funding Information
- >Ministero dell'Istruzione, dell'Università e della Ricerca (RBSI144MT)
- Sapienza Università di Roma (RG116154C9214D1A)
This publication has 25 references indexed in Scilit:
- Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic miceLife Sciences, 2013
- Differential Effects of an O-GlcNAcase Inhibitor on Tau PhosphorylationPLOS ONE, 2012
- Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregationNature Chemical Biology, 2012
- Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic DiseaseAnnual Review of Biochemistry, 2011
- O-GlcNAc modification, insulin signaling and diabetic complicationsDiabetes & Metabolism, 2010
- Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s diseaseJournal of Neurochemistry, 2009
- Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's diseaseBrain, 2009
- Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fastingEuropean Journal of Neuroscience, 2006
- O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 2004
- The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamineJournal of Biological Chemistry, 1996